The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1327
December 14, 2009
View Complete Issue         Table of Contents 2019 
Bone Morphogenetic Protein (Infuse Bone Graft)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Bone Morphogenetic Protein (Infuse Bone Graft)
December 14, 2009 (Issue: 1327)
Harvesting of autogenous bone, most commonly from the iliac crest, for use as the interbody graft in spinal fusion procedures has been standard practice, but is associated with a high rate of morbidity, including graft site pain, infection, fracture,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Bone Morphogenetic Protein (Infuse Bone Graft)
Article code: 1327c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.